SentiSense
Ctrl+K
Quick tip: Press
to search stocks
N
NVS
Novartis AG
$153.44
-0.81 (-0.53%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
1359
tracked filers
Total Institutional Value
$11.7B
1359 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
Notable changes (1)
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
DODGE & COX | Mutual Fund | 10.6M | $1.4B | -- | -0.6% |
PRIMECAP MANAGEMENT CO/CA/ | Other | 9.3M | $1.2B | -- | -10.2% |
DIMENSIONAL FUND ADVISORS LP | Index Fund | 7.8M | $996.4M | -- | -2.4% |
Fisher Asset Management, LLC | Other | 7.2M | $928.4M | -- | +1.7% |
LOOMIS SAYLES & CO L P | Other | 5.0M | $641.2M | -- | +2.0% |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
NVS
Market Cap
$294.33B
IPO Date
Nov 7, 1996
CEO
Vasant Narasimhan
Employees
75,267
Sector
--
Industry
--
Country
United States
Exchange
--
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Read MoreSimilar Stocks
MRNA
Moderna Inc.
$52.56
-1.55%
RHHBY
Roche Holding AG
$50.12
-3.49%